Fundación Aladina shared a post on Facebook:
“At Aladdin Foundation, we believe that advancing against childhood cancer happens by standing by those who research and look for new answers.
This year we celebrate that thanks to the I Beca FERO-Aladina in pediatric cancer, of which Dr. Pablo Menendez was beneficiary, his team was able to promote a research project focused on developing an advanced therapy based on CAR-T cells to treat resistant and metastatic infant sarcomas, an approach that seeks to offer new therapeutic options to children and young people who today do not have them.
And now, we look to the future with a second FERO-Aladdin Scholarship, reaffirming our commitment to science that can transform lives. Because supporting research is also accompanying families, promoting hope and getting a little closer to more effective treatments for those who need it most.”
More posts featuring Fundación Aladina.